 Different characteristics were significantly associated with ABR among children vs. adults, including being 10-17 vs. 2-9 years old, HA vs. HB, having moderate vs. mild hemophilia and annual factor usage per body weight. (Table 2)  Of 477 recruited individuals, 322 with at least three months of participant follow-up surveys, complete follow-up medical information and dispensing records, no inhibitors and complete baseline characteristics were included.  Of those included, 47.2% were adults, 69.3% had HA and 61.5% had severe hemophilia (HA N=151, HB N=47). Significantly fewer individuals on prophylaxis vs. on-demand treatment were adults, had HB or had mild/moderate hemophilia. (Table 1 )  An ABR of 1-10 was recorded in 58% of participants. A higher percentage of adults vs. children with severe hemophilia had ABR ≥11 among those treating on-demand (72% vs. 41%, respectively) and prophylactically (44% vs. 10%, respectively). (Figure 1 )  Among all participants, categorical variables significantly associated with ABR included being 10-17, 27-35 or 36+ vs. 2-9 years old; married/with a partner vs. not married/not with a partner; HA vs. HB; and moderate or severe vs. mild hemophilia. Continuous variables significantly associated with ABR included annual factor usage per body weight and annual factor usage in those on prophylaxis vs. on-demand. (Table 2 )  Among adults, variables significantly associated with ABR included > 12 years of education vs. ≤ 12, annual factor usage per body weight, annual factor usage in those on prophylaxis vs. on-demand and HIV/AIDS vs.
INTRODUCTION OBJECTIVES
 Hemophilia is an inherited bleeding disorder associated with spontaneous and trauma-induced bleeding into joints and soft tissues, which can pose significant economic and quality-of-life (QoL) burdens on persons with hemophilia and their families. Also, some patients develop antibodies (inhibitors) to clotting factor replacement therapy, which increases complications and costs.
(1-3)  Regular infusions of clotting factor to prevent bleeding (prophylaxis treatment) can significantly reduce the annual bleed rate (ABR) compared with infusions following a bleed (on-demand treatment). However, real world data have shown that individuals with hemophilia can still face frequent bleeding episodes despite prophylaxis. (3-5)  Because of the high cost of clotting factor and significant negative impacts of bleeding episodes, it is critical to understand how variations in patient subgroups, treatment regimens, and socio-demographic characteristics might impact ABR. However, few studies have examined the associations between characteristics of individuals with hemophilia and ABR.
 To identify socio-demographic and clinical characteristics associated with ABR in persons with hemophilia A (HA) or hemophilia B (HB).  To examine characteristics associated with ABR between adult and pediatric individuals with hemophilia.  Participants or parents of pediatric participants completed an initial survey with information regarding socio-demographics, clinical characteristics , inhibitor status and treatment patterns.  Follow-up surveys were administered regularly for two years to collect data on bleeding episodes and development of inhibitors.  Two-year dispensing information, including clotting factor usage, was abstracted from dispensing records.
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Variables:
 The dependent variable, ABR, was defined as number of bleeding episodes per year. ABR was calculated from two-year participantreported bleeding episodes annualized by total follow-up time.  Independent variables included annual clotting factor usage from dispensing records and participant socio-demographic and clinical characteristics reported in the initial survey. Statistical analyses:  Multivariable linear regression was used to examine the associations between independent variables and ABR.  The same regression was also examined separately in adult participants ≥18 years of age and in pediatric participants <18 years of age.  In addition to clinical characteristics and treatment regimen, socio-demographic characteristics were also significantly associated with ABR. These results suggest that individual differences and variations in patient subgroups could markedly impact the number of bleeds experienced by a person with hemophilia.  Further, significant differences in ABR and in characteristics associated with ABR existed between adults and children. Notably, in adults, the effect of annual factor usage per unit of body weight on ABR was significantly different among those treating prophylactically vs. on-demand. These preliminary findings suggest potential for treatment optimization in individuals of varying ages and reinforce the importance of adopting a precision medicine approach.  Future studies should investigate how variations in bleeding outcomes, patient characteristics and treatment vary in other hemophilia subgroups and how they are associated with healthcare resource utilization.
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